TABLE 1.
Baseline characteristics in vaccine and control group
| Characteristics | Vaccine group (n = 105) | Control group (n = 155) | p Value |
|---|---|---|---|
| Female age, years | 31.88 ± 4.00 | 31.80 ± 3.86 | 0.878 |
| Male age, years | 33.92 ± 4.70 | 33.25 ± 4.42 | 0.237 |
| Infertility, years | 3.70 ± 2.72 | 3.18 ± 2.22 | 0.089 |
| Female BMI, kg/m2 | 22.12 ± 3.09 | 22.07 ± 3.68 | 0.909 |
| Male BMI, kg/m2 | 24.21 ± 3.54 | 24.36 ± 4.49 | 0.768 |
| Basal serum FSH, IU/L | 7.18 ± 2.15 | 6.94 ± 2.08 | 0.380 |
| AMH, ng/ml | 3.74 ± 2.59 | 3.44 ± 2.16 | 0.313 |
| E2 on hCG trigger day, pg/ml | 2621.86 ± 1227.14 | 2404.04 ± 1225.96 | 0.161 |
| Total dose of Gn, IU | 2419.95 ± 995.34 | 2422.95 ± 881.88 | 0.980 |
| Duration of stimulation, days | 12.10 ± 2.16 | 11.94 ± 1.84 | 0.528 |
Abbreviations: AMH, anti‐Mullerian hormone; BMI, Body Mass Index; E2, oestrogen; FSH, follicle‐stimulating hormone; Gn, gonadotropin; hCG, human chorionic gonadotropin.